SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp broad-market selloff, with traders linking pressure to fears that post-midterm AI regulation could slow data-center investment and weighing broader tech and semiconductor weakness, is dominating SPY discussion. Bears warn of further downside, while dip buyers call the drop overdone and look for a rebound.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias steep selloff is tied to broader AI and semiconductor weakness as traders fear the election outcome could bring tighter restrictions or delays for data-center construction, threatening the pace of AI infrastructure spending. The community is split between viewing the drop as panic and a buying opportunity and worrying that slower buildout could expose an AI-investment bubble.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under heavy selling pressure as traders worry that political pushback against data centers could slow AI infrastructure spending, adding to concerns that the AI trade is overvalued and vulnerable to forced selling. The community is split between seeing a deeper AI-led unwind and viewing the drop as an overreaction that may draw dip buyers.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor and tech selloff, amid fears that AI infrastructure spending could slow and speculation about political pushback on data centers, has hammered the 3x leveraged SOXL fund. Traders debate whether the drop signals an AI-bubble unwind or an overreaction, while many try to buy the dip and others warn of further losses amplified by leverage.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys rejection of Trian Partners takeover proposal and adoption of a limited-duration shareholder rights plan dominate discussion, with many traders calling the bid too low and hoping for a higher offer. Others question the companys weak sales and turnaround prospects, while speculation about a short squeeze remains prominent.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

A steep selloff ahead of the earnings report has put AAOIs results and outlook at the center of discussion, amid broader worries about AI infrastructure spending and photonics stocks. Traders are split between buying the pullback in anticipation of strong results and expecting further losses if the report or guidance disappoints.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is drawing attention ahead of its quarterly report, with traders focused on reported delays at its Texas data-center buildout tied to Microsoft and whether management can offer credible execution and guidance. Bearish traders fear further weakness amid pressure on AI infrastructure stocks and political uncertainty, while bulls argue the selloff is overdone and hope for reassuring results.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a sharp semiconductor selloff as traders worry that new AI regulation and possible data-center restrictions could slow infrastructure spending and chip demand. The community is split between dip buyers citing persistent memory demand and strong fundamentals, and bears expecting further declines amid AI-trade fears and forced selling.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is caught in a sharp semiconductor and AI-stock selloff as traders worry that a Democratic sweep and potential data-center restrictions could slow AI infrastructure spending, despite the companys strong results and outlook. The community is split between dip buyers who see the decline as an overreaction and bears who warn that AI spending may cool and valuations remain stretched.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

A sharp broad-market selloff has put VOO in focus, with traders attributing the drop to political uncertainty and a possible unwind in AI and technology stocks. Reactions are split between dip-buyers and investors warning of a deeper downturn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-market session. The company's market cap stands at $11.0 million.
BioRestorative Therapies (NASDAQ:BRTX) stock movedread more...

OSRH Stock Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock

Equity

The company signed a global licensing deal with BCM Europe that could bring in up to $815 million in milestone payments.

OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?

OSR Holdings shares surged 41.28% after securing a global exclusive licensing deal for its Phase 3-ready cancer immunotherapy VXM01, with potential milestone payments up to $815 million.read more...

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials PR...

Why Did OSRH Stock Jump 20% Today?

The company received an additional 180-day extension from Nasdaq to regain compliance after receiving an initial notice on Sept. 9, 2025.

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical...

Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to...

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones Vaximm, an OSR Company, Receives Binding Term...

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings PR...

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period...

OSR Health, Inc. operates as a global healthcare company. The firm engages in developing oral immunotherapies for cancer treatment, design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention of medical devices and systems distribution in Korea. Its products are offered through its subsidiaries. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.

OSR Health Inc.

Neutral Sentiment

<ul class="summary-bullets"><li>The deal is expected to advance its cancer immunotherapy candidate VXM01, which has shown promising results in early studies for glioblastoma and pancreatic cancer.</li><li>Under the agreement, BCME will get exclusive rights to develop, manufacture, and commercialize the drug.</li><li>BCME has pledged its nearly 30% stake in the OSRH as collateral to back the milestone payments.</li></ul>Shares of OSR Holdings Inc. (OSRH) soared 60% on Thursday, marking their biggest one-day jump in over eight months, as investors welcomed a newly finalized global licensing deal that could bring in up to $815 million in milestone payments.OSR Holdings signed an agreement with BCM Europe (BCME) to advance its cancer immunotherapy candidate VXM01, an oral treatment targeting VEGFR-2, a protein found on blood vessels that helps control how blood cells grow and survive.VXM01 has shown promising results in early studies for aggressive cancers such as glioblastoma and pancreatic cancer.<h2 class="st-heading-2">$815M Licensing Deal</h2>Under the agreement, BCME will get exclusive rights to develop, manufacture, and commercialize the drug, while OSR could receive up to $815 million in milestone payments tied to clinical, regulatory, and commercial progress.BCME, OSR’s largest shareholder, has pledged its nearly 30% stake in the company as collateral to back the milestone payments. OSR will also earn full royalties after BCME recovers its investment.“This agreement establishes a clear, accountable framework for the development of VXM01. It ensures OSR Holdings shareholders participate directly in value creation, while BCME remains accountable for its financial commitments,” said Peter Hwang, CEO of OSR Holdings.<h2 class="st-heading-2">Retail Bulls Expect Stock To Hit The $1 Mark</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/OSRH">OSRH</a> on Stocktwits remained in the ‘extremely bullish’ territory over the past 24 hours, amid ‘extremely high’ message volumes.Users expect the stock to climb to $1, following the latest update. The stock last traded at that level on Aug. 26, 2025.<stembedurl>https://stocktwits.com/Stellarspider/message/651893470</stembedurl><stembedurl>https://stocktwits.com/sadalmas/message/651891224</stembedurl>Over 193 million shares changed hands on Thursday, compared to the daily average of roughly 1.1 million, according to Stocktwits data.The company first received a Nasdaq notice in September for failing to meet the $1 minimum share price requirement and was initially given until March 4, 2026, to regain compliance. It has now been granted an additional 180 days, giving it until Aug. 31, 2026, to meet the requirement.The stock has gained 15% so far in 2026.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

OSRH Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Current Price	$0.1474
Prev Close	$0.16
Open	$0.15
Dividend Yield	0.00%
50-Day Moving Average	$0.212
Beta	0.41
Avg. Volume	188,427.95
PE Ratio	-0.40

52-Week High	$0.90
52-Week Low	$0.075
Market Capitalization	$5.62M
EPS (Annual)	-$0.9229
Price to Book	0.05
Revenue Per Employee	$132,082.05

Feed

News

Sentiment

Fundamentals

Info

OSRH Fundamentals